Malcolm Noonan (Carlow-Kilkenny, Green Party) | Oireachtas source

Again, I will defer to Mr. Moore on the specifics. As we see it, however, the stakeholders are our research institutions and the pharmaceutical companies that have a very strong presence in Ireland. I am speaking about research organisations such as Teagasc, the Intellectual Property Office and the National Botanic Gardens. These bodies, as we would see it, would be the users of these genetic resources. The National Botanic Gardens are a great repository for genetic resources in the context of their wider work around research.

As we see it in terms of implementation, under the requirements of access and benefit sharing, ABS, we would establish a stakeholder group to look at the implementation of the protocol and how organisations in Ireland, as a user country, would meet its requirements. I will ask Mr. Moore to speak about the specifics of this.